Here are the biggest calls on Wall Street on Monday:
Evercore ISI upgrades FFIV to Outperform from In Line
Evercore said the stock is becoming an EPS “compounder.”
“We are upgrading FFIV to Outperform from In Line and raising our price target to $475 (~31% upside), as five reinforcing drivers reposition the company into a high-single-digit revenue / low-double-digit EPS compounder.”
Williams Trading upgrades VFC to Buy from Sell
The firm cited improving momentum at Vans and other positive catalysts ahead.
“Upgrading from Sell to Buy, raising PT from $14 to $19, and raising estimates. The double upgrade is a result of subtle increase in momentum within Vans, led by the LX Old Skool Pearlized Pack.”
Wells Fargo upgrades VIK to Overweight from Equal Weight
Wells said Viking’s earnings trajectory remains compelling.
“Despite the Iran conflict, fundamentals for VIK’s core business continue to not only improve y/y but accelerate.”
JPMorgan upgrades BALL and CCK to Overweight from Neutral
The bank cited valuation for both aluminum can producers.
“We upgrade Ball and Crown ... based on valuation.”
Goldman Sachs initiates AMX with a Buy rating
Goldman pointed to strong operational momentum across Latin America.
“Our relative preference for AMX is based on its positive operational momentum, especially in Mexico and Brazil.”
Bernstein initiates ARM as Outperform
Bernstein said the chip designer is firing on all cylinders.
“The business now relies on three revenue streams ... licensing revenue, royalty revenue, and software/access monetization.”
Morgan Stanley upgrades LRCX to Overweight from Equal Weight
The bank said the stock still has room to run.
“Given our confidence on LAM’s 2027 share gains ... we raise our price target from $293 to $331.”
HSBC upgrades SHEL to Buy from Hold
HSBC sees further upside from shareholder returns and buybacks.
“Shell’s 2026 yield remains the highest among large-cap oil majors.”
Barclays initiates Yesway as Overweight
Barclays said the convenience-store operator is well positioned for growth.
“Yesway is an attractive growth story with a unique model.”
Raymond James upgrades INVH and AMH to Outperform
The firm expects housing legislation to remove key industry overhangs.
“We believe the House’s new version is receiving bipartisan support.”
Roth initiates ELMT with a Buy rating
Roth highlighted the company’s differentiated exposure to critical minerals and infrastructure products.
“Elmet is a unique provider of precision engineered components and high-powered microwave devices.”
Morgan Stanley reiterates MKSI as Overweight
The bank named the semiconductor equipment maker a new top pick.
“MKS is our favorite way to play our positive view on 2027 NAND WFE.”
Bank of America reinstates CRM as Underperform
The bank cited multiple negative catalysts ahead.
“We are reinstating coverage with an Underperform and a $160 PO.”
Truist initiates TJX with a Buy rating
Truist sees strong execution in the off-price retail channel.
“The off-price channel offers a very attractive value proposition.”
Truist initiates ROST as Buy
The firm cited favorable industry tailwinds and store expansion opportunities.
“We believe LT topline growth visibility for ROST is robust.”
Bank of America reiterates NFLX as Buy
The bank said Netflix still has a long runway for advertising growth.
“NFLX is continuing to improve its advertising offering with new formats and more technology.”
Morgan Stanley reiterates NVDA as Overweight
The firm raised its price target to $285 from $265.
“Expecting continued upside to numbers and a bullish tone on key debates.”
DA Davidson downgrades CRWV to Neutral from Buy
The firm cited a more balanced risk/reward profile.
“We remain skeptical of CoreWeave’s ability to generate sufficient returns given its margin profile and high dependence on debt financing.”
Jefferies reiterates AMZN as Buy
The firm added Amazon to its franchise picks list.
“AWS is in the early stages of a meaningful re-acceleration.”
H.C. Wainwright upgrades CRCL to Buy from Neutral
The firm pointed to growing “value creation” following Arc token developments.
“We are upgrading our rating on CRCL to Buy from Neutral and raising our price target to $150.”
Comments